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In the absence of hard data, is soft data better than no data at all? 
Introduction 
Between 1996 and 1999, the author was Research Fellow on a project investigating 
a non-clinical and non-criminal heroin using population.   
The inclusion criteria for this study were that participants had non-medically used 
opiates at least 10 times in each of the previous 2 years, had never received any 
specialist addiction treatment for any drug (including alcohol), and had never served 
a custodial sentence.  
 
In total, 176 participants were interviewed for the project; the methodology stated 
that each of these would be required to be interviewed in total three times over the 
space of 36 months. For a number of different reasons, 126 participants were 
interviewed the required three times. What the results of this study indicated was 
that, under the correct conditions, it was hypothetically possible to use opiates in 
general and heroin specifically over a number of years without necessarily 
encountering the problems normally associated with the non-medically supervised 
use of these substances. The results of both the pilot study and the main study have 
been published (Shewan, Dalgarno, Marshall, Lowe et al 1998; Shewan and 
Dalgarno, 2005). These findings have been replicated to a degree by a similar study 
conducted in England (Warburton, Turnbull & Hough 2005; McSweeney & Turnbull, 
2007). 
 
In 2011 the author applied for further funding to revisit this cohort in order to follow 
them up with a view to investigating whether or not they still used heroin and, if so, 
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whether their use could still be regarded as non-problematic, and if not, had any of 
them sought specialist treatment?  It was assumed that a number of the group would 
have discontinued use, in which case the questions would focus on why had they 
decided to stop and how had they managed it: had they sought some form of 
medical assistance, had they "done it themselves" or had they simply stopped 
without thinking about it? 
In the event, the application was rejected. There were several reasons given for this 
by the funding organisation, principal of which was the reliance in the proposed 
follow-up study on subjective "soft" data, in the form of self-complete questionnaires. 
In 2013, the author met with medical colleagues to discuss further possibilities for 
this cohort, this time addressing the specific issues that had been raised by the 
reviewers of the application two years earlier. 
Rather than using self-complete questionnaires, it was proposed that "hard" data, in 
the form of medical records be accessed via a number of NHS databases, and the 
non-problematic heroin cohort compared with an age and gender matched "normal" 
population sample along with another sample of stable methadone users (also age 
and gender matched). The method was straightforward: health and medical data for 
the three groups would be tracked and compared for the years 1996/7, 1999 and 
2012. This would give some indication of whether the study group were more or less 
healthy than the two comparison groups in terms of GP visits, hospitalisations, 
psychiatric problems and so forth. This was a clear and simple plan and would 
generate a considerable amount of data for analysis based upon objective medical 
records rather than subjective self-reporting and interviewer observation.   
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In order to do all of this, however, the real names of the original participants along 
with their date of birth would be required. Ideally, postcodes for their addresses in 
1996/7, 1999 and 2012 should also be provided. Lastly, a signed consent form would 
be required in order to gain access to their medical records. 
The potential problems with this were immediately clear as information of this sort 
was precisely what had not been asked for at the time of the original project, where 
the only details collected were gender, age, occupation of the participant and the 
occupations of their parents. This was one of the basic assurances given to 
participants at the outset of the 1996 study and was regarded as an absolute 
necessity. Had this assurance not been given then it is doubtful that the project 
would have progressed beyond the pilot stage. The current emphasis on verifiable 
medical and other such “hard” data as a means of squeezing further value for money 
out of a project is not feasible in the case of individuals or groups who have not 
come to the attention of the medical/addiction or criminal justice systems. 
These concerns notwithstanding, a number of discreet messages were posted on 
social networking sites, a number of telephone calls made and a number of meetings 
held. Within ten days there had been direct responses from over fifteen individuals 
(all male), two of these were on behalf of an undisclosed number of other parties. 
Another individual made contact on behalf of himself and two others, all three of 
whom are currently in specialist addiction treatment. None of the others who made 
contact had been or were currently in treatment.  
The majority of replies came from individuals who had been key contacts on the 
1996 project. In essence, they had been participants at an early stage and had 
agreed to approach others in their social group of heroin users with a view to 
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recruiting them to the study. A number of these outreach people were used 
throughout the study, and the author maintained contact of sorts with some of them 
at the end of its lifespan. This provided a means of indirectly keeping in touch with 
those individuals they had introduced to the project. Using the original key contacts 
as a buffer between participants and researcher also provided a reasonable means 
of further protecting the participants’ anonymity, as it would be left up to them 
whether they wanted to participate in a follow-up or not via a proxy. 
With the exception of those in treatment, none of the others were prepared to take 
part in the proposed study despite taking the time to contact the author. There were 
several reasons given for this decision (none of which relate to health concerns, 
interestingly). These were as follows: 
1. “Owning up to” an illegal activity, in this case, heroin use. None of those who 
made contact had attracted the attention of the police (this applied to the 
problem users now in treatment) and signing a consent form for a project 
investigating their heroin use was regarded as tantamount to signing a 
confession. 
2. Related to the above (and arguably more important) was the issue of stigma 
(and public shame) to the participant should the data ever “get into the wrong 
hands” resulting in them being “outed” as heroin users (whether current or 
former). It was thought that should this knowledge become public then their 
livelihoods, reputations and relationships with others (in some cases, their 
spouses, who were unaware of this part of their lives) would be jeopardised.   
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3. While every reassurance was given as regards ethics, particularly around 
anonymity and confidentiality, the correspondents remained resolutely 
unconvinced. There was concern expressed that the rules/laws covering 
ethics could be changed at some point in the future leading, again, to potential 
exposure as a heroin user, linking back to concerns 1 and 2 (above).  
4. Concerns were raised about the security of the data, with a number of people 
raising the issue of high profile stories in the media about NHS laptops and 
data sticks being left in taxis, cafes and so forth. 
In short, none of these non-criminal, healthy adults appeared to have any great faith 
or trust in what they perceive as governmental agencies – in this case the NHS and 
the university system – and by extension the government itself. It should be noted 
that this mistrust was present in those individuals in treatment as well, even though 
they were prepared to provide the required details, taking the view that, as they were 
already “in the system” everything was known about them already and that they had 
little to lose in this respect.  
That said, all of those who took the step of, as it were, making the initial move and 
getting in touch were amenable to the idea of a one on one interview with no 
identifiers (other than those used in the original study: age, gender, occupation) 
being conducted in a place of their choice by a discreet and experienced interviewer. 
Discussion 
This situation clearly poses a problem in terms of research involving the intersection 
of health and illegal activity, particularly where the activity – in this case the use of a 
substance commonly regarded as highly addictive – has to date been conducted 
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discreetly and unobtrusively enough so as not to result in any clear or obvious health 
problems, nor attracted the attentions of the law enforcement agencies. 
On the face of it, the situation appears to be quite clear cut; black and white, so to 
speak. On one side we have those who abstain from the consumption of any sort of 
(illegal) intoxicant, and on the other we have a group of highly problematic and highly 
visible users who are already involved with addiction services and/or the criminal 
justice system due at least in part to the severity of their drug problem(s): in 
reductionist terms, one is either abstinent or one is an addict. 
However, sitting between these two extremes, there is a third, very heavily populated 
“grey middle group”.  One would assume that anyone working in the drugs field will 
at the very least be aware of the people populating this group: they are not abstinent 
but nor are they especially problematic, and will use a particular illegal drug (usually, 
but not always, cannabis) or perhaps a range of illegal drugs (usually, but not 
always, stimulants and “party drugs” such as Ecstasy, amphetamines and LSD). A 
number of them will use drugs which, to the uninitiated or uninformed, are usually 
associated with the highly problematic group, drugs such as cocaine, crack cocaine 
and the opiates, specifically heroin.  
Due to the fact that nothing current is really known about this group, what follows is 
largely educated guesswork on the part of the author; these are drug or ex-drug 
using non-criminals most of whom are now completely integrated into some social 
group with all the trappings and status symbols accompanying that. From the 
responses received to the “invitation to participate” messages, it would seem that 
many/most of their friends know nothing about their opiate/drug use (either current 
or past); this may be a wise strategy, as users of substances generally regarded 
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(often erroneously) as “recreational” such as Ecstasy can often take a negative view 
of heroin use (e.g. McElrath & McEvoy, 2001; Finnigan, 1996). 
There is the added possibility that their partners do not even know about their heroin 
use. It has been proposed that popular views and beliefs regarding how drug users 
“are” can stigmatise and thus negatively affect users (and probably, in this case, 
former users). This applies particularly when the views and beliefs stem from 
ignorance and misinformation (Palamar, 2013, Palamar et al, 2013). 
Brown (2015) makes the point that stigma may be more or less severe depending on 
the drug involved; his study comparing levels of stigma towards cannabis users with 
heroin users, indicate that the “harder” a substance is considered to be, the greater 
the levels of stigma are.   
These findings are in accordance with a study conducted by Palamar (2012) 
regarding stigma perceptions towards those who use substances ranging from those 
considered “soft” to those considered “hard”. The overall suggestion is that users of 
“hard” drugs may be more affected by stigma.  
As an aside, it is noteworthy that all of the studies the author reviewed regarding 
substance use and the resulting stigma (perceived or otherwise) focus on current 
and/or problem use as opposed to previous and/or occasional use. Regardless, the 
perceived impacts of having been a heroin user in the past, occasional and 
controlled or otherwise, do appear to cast a long shadow. 
It could be assumed from the above that the participants in the proposed study were 
(understandably) concerned about stigmatising arising from past behaviours that 
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they either no longer indulge in, or indulge even more discreetly than previously: post 
hoc stigmatising, as it were. 
With all the hullaballoo and stigma associated with drug use (e.g. Boekel et al 2015; 
Erofeeva, 2016; Scheibe, 2017) - let alone the use of a "demon drug" like heroin - 
the reluctance to come forward is understandable. The reluctance appears to 
increase exponentially when the group in question are in their late 30's to late 50's, 
have families, commitments and probably at (the very least) some sort of semi-
respectability in the eyes of their friends and colleagues. This is known as “the 
recanting effect” (see, for example, Erowid 2005). 
A further point worthy of note is that all of the parties who responded to the 
participation messages were male. Traditionally (in non-gender specific projects), 
recruiting female participants for drug research projects has proved problematic. The 
original heroin project was no different in this respect and by the end of the data 
collection period 32 of the viable 126 cases were female. This represents 25% of the 
final sample included in analysis.  
There have been a number of reasons proposed for the gender disparity in drug 
research, one of which is that women are less likely to participate because they see 
themselves as having “more to lose” than men and face much greater levels of 
stigma and social ostracisation. Such stigmatising attitudes are found among health 
professionals (Samuelsson & Wallander, 2014) and they appear to apply particularly 
if the women are parents (see, for example Simpson & McNulty, 2008). 
Of course, one cannot say with any certainty why none of the female participants 
chose to make contact; the reason could be as prosaic as none of them had heard 
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about or seen the invitations – these were, as already noted, made both discreetly 
and cryptically. Or possibly, if they had heard about or seen these, they were too 
busy with other domains of their lives to commit themselves. Or perhaps it could be 
assumed that, as nearly fifteen years had passed since the original project, the lives 
of the women participants had arguably changed even more than their male 
counterparts in the form of principal care provider to children, for example. If this is 
the case, then it underscores the “more to lose” point made above. 
As noted, none of the correspondents had any apparent concerns around what the 
actual effects of long-term drug use might be having on their longer-term health 
(comparison with an age and gender matched “normal” sample of – supposed – non-
drug users and a “stable” methadone sample would have yielded some data on this): 
all of the concerns were around being "outed”, not only as a drug user but as a 
heroin user, and the subsequent personal and social problems this could potentially 
cause.  
And yet, none of them were particularly averse to the idea of disclosing further detail 
regarding their heroin use – or non-use – to a suitably vetted, qualified and 
experienced researcher, either in the form of questionnaires and standardised 
measures or the taking of notes; as long as their right to total anonymity and 
confidentiality was understood and upheld. 
The problem with this, of course, is that what is yielded from work of this kind is 
subjective, “soft” data, and this is something that few funders seem prepared to 
countenance, as it is regarded as of less consequence than data of the more 
objective and verifiable (and, depending on what is being researched, almost 




While it is completely understandable that “hard” data is increasingly regarded as 
something of a gold standard, there are clear drawbacks to this when it comes to 
specific “hidden” populations (particularly regarding participation in activities 
perceived to be of an "aberrant" nature involving drugs and/or sex) the behaviours of 
whom are likely to result in censure, moral outrage and stigmatization; and these 
have implications and consequences. 
First and foremost, very few funding bodies seem prepared to award grants to 
researchers working with “soft” data. The above raises questions regarding the fairly 
narrow scope of this research remit. 
Potentially, there is an element here of absence of proof possibly being taken as 
“proof of absence” as regards what I have termed the “grey middle group” that sits 
between the black and white of problem users and abstainers. In reality, they exist, 
but in actuality, there is very little/no hard evidence that “proves” their existence as 
they are – to an extent, quite understandably given their circumstances – completely 
opposed to providing the personal details necessary for the gathering of “hard” and 
“objective” data. 
In the light of the above, it may also be necessary to re-evaluate the accuracy and 
relevance of national crime and health surveys. 
In recent years it has been noted that there is an increasing population of older/aging 
illicit drug users (e.g. Drugscope, 2014). This will presumably be an ongoing situation 
and while almost certainly it will primarily concern older problem users, there may 
also be a case to be made for provision for life-long recreational users, as the 
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accumulated effects of decades of non-problematic use (be that occasional or 
something more than occasional) become apparent. Given the concerns of users - 
and for all we know, ex-users - around disclosure of their recreational drug use, this 
may prove a tough nut to crack. 
The aborted project was intended to be the first phase of a larger study, the overall 
aim of which was to investigate "resilience" to the problems associated with heroin 
use. Ironically, this "resilience" may at least in part be due to the steadfast refusal of 
non-problematic users to compromise their anonymity. 
For a number of years, the author has taken the view that, rather than focussing 
solely upon clinical and/or criminal samples in order to determine, so to speak, “why 
are they as they are”, researchers could also focus on the hidden/unobtrusive “grey 
middle” group in order to determine why they are not like the clinical/criminal groups: 
what makes them different?  
This, of course, is clearly easier said than done and, at least in terms of 
accumulating hard data, presents significant challenges, particularly around the 
issues of personal identifiers and signed consent forms. We need to consider 









Boekel, L., Brouwers, E., Weeghel, J. & Garretsen, H. (2015) Comparing 
stigmatising attitudes towards people with substance use disorders between the 
general public, GPs, mental health and addiction specialists and clients. 
International Journal of Social Psychiatry, 61(6): 539-549. 
Brown, SA (2015) Stigma towards Marijuana Users and Heroin Users. Journal of 
Psychoactive Drugs, 47(3), 213-220. 
Drugscope (2014) It’s about time: Tackling substance misuse in older people. 
Retrieved 24th July 2015 from: 
http://www.drugscope.org.uk/POLICY+TOPICS/OlderPeople  
Erofeeva, P (2016) The stigmatization of alcohol and drug dependence: its scope 
and consequences. Journal of Social Policy Studies, 14(3): 377-392. 
Erowid (2005) retrieved 24th July 2015 from 
https://www.erowid.org/psychoactives/statistics/statistics_article2.shtml 
Finnigan, F (1996) How non-heroin users perceive heroin users and how heroin 
users perceive themselves. Addiction Research, 4(1): 25-32. 
McElrath K & McEvoy K (2001) Heroin as Evil: ecstasy users’ perceptions about 
heroin. Drugs: Education, Prevention and Policy, 8(2) 177-189. 
McSweeney, T & Turnbull, P.J. (2007) Exploring user perceptions of occasional and 
controlled heroin use: a follow-up study. Joseph Rowntree Foundation, York 
13 
 
Palamar, JJ (2012) A pilot study examining perceived rejection and secrecy in 
relation to illicit drug use and associated stigma. Drug and Alcohol Review 
31(4):573–79. 
Palamar, JJ (2013) An Examination of Beliefs and Opinion about Drug Use in 
Relation to Personal Stigmatization towards Drug Users. Journal of Psychoactive 
Drugs, 45(5), 367-373. 
Palamar, JJ, Halkitis, PN & Kiang, MV (2013) Perceived public stigma and 
stigmatization in explaining lifetime illicit drug use among emerging adults. Addiction 
Research and Theory, 21(6), 516-525. 
Samuelsson E & Wallander L (2014) Disentangling practitioners’ perceptions of 
substance use severity: A factorial survey. Addiction Research and Theory, 22(4), 
348-360. 
Scheibe, L (2017) Visualising "junkies" and "meth heads" - a visual analysis of the 
persistent negative reputation of heroin and meth users. Drugs and Alcohol Today, 
17(1): 40-49. 
Shewan, D. & Dalgarno, P. (2005) Low levels of negative health and social 
outcomes among non-treatment heroin users in Glasgow (Scotland): Evidence for 
controlled heroin use. British Journal of Health Psychology, 10, 33-48. 
Shewan, D., Dalgarno, P., Marshall, A., Lowe, E. et al (1998) Patterns of heroin use 




Simpson, M. & McNulty, J. (2008) Different needs: Women's drug use and treatment 
in the UK. International Journal of Drug Policy, 19(2), 169-175. 
Warburton, H., Turnbull, P.J. & Hough, M. (2005) Occasional and controlled heroin 
use: not a problem? Joseph Rowntree Foundation, York. 
